DGX — QUEST DIAGNOSTICS INC
—
NYSE ·
Health Care ·
Health Care Providers & Services ·
CIK 1022079 ·
Last close
$256.35
Market Cap
$28.29B
52W High
$263.19
52W Low
$168.35
ADV30
951,901
Next earnings
2026-10-22
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | — | — | — | — | — | — | — |
| Jun 2026 | 3,043,000,000 | 1,027,000,000 | 459,000,000 | 320,000,000 | 16,939,000,000 | 626,000,000 | 9,040,000,000 |
| Mar 2026 | 2,895,000,000 | 942,000,000 | 404,000,000 | 252,000,000 | 16,673,000,000 | 393,000,000 | 8,928,000,000 |
| Dec 2025 | 2,806,000,000 | 910,000,000 | 386,000,000 | 245,000,000 | 16,225,000,000 | 420,000,000 | 8,939,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$1,903,000,000
Investing CF
$-678,000,000
Financing CF
$-915,000,000
CapEx
$-554,000,000
Dividends Paid
$-363,000,000
Buybacks
$-450,000,000
EPS Diluted TTM
$9.42
As of
2026-10-25
Balance + Analyst (yfinance extras)
Retained Earnings
$10,374,000,000
Inventory
$233,000,000
Receivables
$1,666,000,000
ST Investments
—
EBIT TTM
$1,673,000,000
Pretax Income TTM
$1,404,000,000
Interest Exp TTM
$269,000,000
Analysts
15
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,841,000,448
EBITDA
$2,352,000,000
Free Cash Flow
$872,499,968
Enterprise Value
$32,611,514,368
Total Cash
$797,000,000
Total Debt
$6,397,000,192
Shares Out
110,373,360
Trailing EPS
$9.42
Book Value
$68.33
ROE
15.3%
ROA
6.6%
Div Yield
1.42%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,035,000,000 | 1,556,000,000 | 992,000,000 | 16,225,000,000 | 8,939,000,000 | 7,170,000,000 | 1,886,000,000 |
| Dec 2024 | 9,872,000,000 | 1,346,000,000 | 871,000,000 | 16,153,000,000 | 9,257,000,000 | 6,778,000,000 | 1,334,000,000 |
| Dec 2023 | 9,252,000,000 | 1,262,000,000 | 854,000,000 | 14,022,000,000 | 7,604,000,000 | 6,307,000,000 | 1,272,000,000 |
| Dec 2022 | 9,883,000,000 | 1,428,000,000 | 946,000,000 | 12,837,000,000 | 6,830,000,000 | 5,893,000,000 | 1,718,000,000 |
TTM Snapshot
Revenues TTM
$11,560,000,000
NetIncome TTM
$1,062,000,000
OpCashFlow TTM
—
Assets (Latest)
$16,939,000,000
Forward EPS
$12.03
Max Pain — expiry 2027-02-19
max pain strike: $230.00 · spot: $259.69 · call oi: 1,894 · put oi: 379
Expected Move to 2027-02-19:
±$28.74
(11.07%) —
implied range
$230.95 –
$288.43
· ATM straddle on $260.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LH | LABCORP HOLDINGS INC. | $29.90B | $368.24 | — |
| THC | TENET HEALTHCARE CORP | $22.45B | $282.07 | — |
| GH | Guardant Health, Inc. | $19.38B | $143.28 | — |
| NTRA | Natera, Inc. | $41.68B | $287.47 | — |
| BTSG | BrightSpring Health Services, Inc. | $13.90B | $69.83 | — |
News headlines (Yahoo Finance, 1h cache)
Mammogen Launches Leadership Council to Unite Industry Experts and Survivors, Names Former Quest Diagnostics CMO Dr. Yuri Fesko as Founding Member
2026-11-17 12:02 · Yahoo
Should Labcorp Stock Holders Look At Quest Diagnostics Instead?
2026-11-13 17:25 · Yahoo
Quest Diagnostics (DGX) Reaffirms Dividend, Is The Stock Already Fully Valued?
2026-11-13 11:10 · Yahoo
Quest Diagnostics (DGX) Stock Could Be 31% Undervalued Following RESULTS Act Push
2026-11-13 09:16 · Yahoo
What Happened To People Who Bought Quest Stock At A High?
2026-11-11 17:41 · Yahoo
Quest Diagnostics Declares Quarterly Cash Dividend
2026-11-10 21:06 · Yahoo
Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference
2026-11-09 17:40 · Yahoo
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London
2026-11-09 17:38 · Yahoo
Global Cardiovascular Genetic Testing Market Report 2026 | Capitalize on 11% CAGR and AI Genomics with Labcorp, Quest Diagnostics, Illumina, and Fulgent Genetics
2026-11-09 14:08 · Yahoo
Stryker announces intention to nominate Jim Davis to board of directors
2026-11-09 21:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.